New electric pulse treatment aims to tame atrial fibrillation

NCT ID NCT07162597

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new procedure called pulsed field ablation (PFA) using the FARAPULSE system to treat people with paroxysmal atrial fibrillation, a type of irregular heartbeat. Researchers will enroll 200 Chinese patients to see if the procedure can safely isolate the veins that trigger the condition. The goal is to offer a gentler alternative to standard heat-based ablation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pulsed field ablation (FARAPULSE system)
What this could lead to
If successful, this could offer a safer, faster alternative to standard heat-based ablation for controlling atrial fibrillation.
What could go wrong
This is a single-center, single-arm study with no control group, so results may not apply broadly. Long-term success and safety are still being evaluated.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (PAROXYSMAL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.